RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Timothy Turner to Antineoplastic Agents

Back to Details
This is a "connection" page, showing publications Timothy Turner has written about Antineoplastic Agents.
Timothy Turner
Connection Strength
0.234
Antineoplastic Agents
  1. Yates C, Sharp S, Jones J, Topps D, Coleman M, Aneja R, Jaynes J, Turner T. LHRH-conjugated lytic peptides directly target prostate cancer cells. Biochem Pharmacol. 2011 Jan 01; 81(1):104-10.
    View in: PubMed
    Score: 0.219
  2. Wang H, Jones J, Turner T, He QP, Hardy S, Grizzle WE, Welch DR, Yates C. Clinical and biological significance of KISS1 expression in prostate cancer. Am J Pathol. 2012 Mar; 180(3):1170-1178.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support